Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Hypertension

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    March 2026
  1. WHELTON PK, O'Connell S, Mills K
    Evolution in the targets for blood pressure treatment.
    Curr Opin Nephrol Hypertens. 2026;35:141-149.
    PubMed     Abstract available


  2. WEHBE F, Hiremath S
    Cuffless blood pressure in 2025: from promise to practice: a narrative review.
    Curr Opin Nephrol Hypertens. 2026;35:164-173.
    PubMed     Abstract available


    January 2026
  3. SAXENA M, He FJ, Caulfield MJ
    New pharmacological therapies for hypertension.
    Curr Opin Nephrol Hypertens. 2026 Jan 23. doi: 10.1097/MNH.0000000000001163.
    PubMed     Abstract available


  4. GUPTA R
    Managing hypertension and cardiovascular risk in resource-limited settings.
    Curr Opin Nephrol Hypertens. 2026 Jan 20. doi: 10.1097/MNH.0000000000001161.
    PubMed     Abstract available


  5. O'CONNELL SS, Whelton PK, Mills KT
    Global trends in hypertension prevalence, awareness, treatment, and control.
    Curr Opin Nephrol Hypertens. 2026 Jan 7. doi: 10.1097/MNH.0000000000001151.
    PubMed     Abstract available


  6. TANTIRIGE NN, Gray JM, Wilkinson IB
    Hypertension guidelines need to be patient oriented.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001154.
    PubMed     Abstract available


  7. HASELER E, Sinha MD
    Tackling the epidemic of obesity and hypertension in children and young people.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001156.
    PubMed     Abstract available


  8. DHERANI M, Wagner SK, Shantsila E
    The role of artificial intelligence in hypertension management.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001157.
    PubMed     Abstract available


  9. TANTISATTAMO E, Rattanasompattikul M, Traitanon O, Eguchi N, et al
    Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges.
    Curr Opin Nephrol Hypertens. 2026;35:43-51.
    PubMed     Abstract available


    December 2025
  10. HERNANDEZ MF, Chang TI
    Pros and cons of lower blood pressure targets in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Dec 30. doi: 10.1097/MNH.0000000000001153.
    PubMed     Abstract available


    July 2025
  11. BOURDON F, Ponte B, Dufey Teso A
    The impact of sex on blood pressure.
    Curr Opin Nephrol Hypertens. 2025;34:322-329.
    PubMed     Abstract available


    May 2025
  12. ROSSI GP, Bagordo D, Rossi FB
    Rethinking arterial hypertension: the need for a paradigm shift.
    Curr Opin Nephrol Hypertens. 2025;34:259-266.
    PubMed     Abstract available


  13. HUANG JX, Peschard VG, Ku E
    Impact of intensive blood pressure control on kidney outcomes.
    Curr Opin Nephrol Hypertens. 2025;34:224-231.
    PubMed     Abstract available


    April 2025
  14. COPUR S, Burlacu A, Kanbay M
    Novel approaches in antihypertensive pharmacotherapeutics.
    Curr Opin Nephrol Hypertens. 2025 Apr 23. doi: 10.1097/MNH.0000000000001081.
    PubMed     Abstract available


    November 2024
  15. TANTISATTAMO E, Ferrey AJ, Reddy UG, Redfield RR 3rd, et al
    Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2024 Nov 11. doi: 10.1097/MNH.0000000000001045.
    PubMed     Abstract available


  16. TAAL MW
    Optimizing kidney and cardiovascular protection in an era of multiple effective treatments.
    Curr Opin Nephrol Hypertens. 2024;33:551-556.
    PubMed     Abstract available


    September 2024
  17. ABDELLATIF DA
    Social and humanitarian issues in nephrology and hypertension.
    Curr Opin Nephrol Hypertens. 2024 Sep 12. doi: 10.1097/MNH.0000000000001026.
    PubMed     Abstract available


    June 2024
  18. TUTTLE M, Sarnak MJ, Navaneethan SD
    Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jun 20. doi: 10.1097/MNH.0000000000001008.
    PubMed     Abstract available


    May 2024
  19. BANSAL S
    Revisiting resistant hypertension in kidney disease.
    Curr Opin Nephrol Hypertens. 2024 May 13. doi: 10.1097/MNH.0000000000001002.
    PubMed     Abstract available


    April 2024
  20. DISSANAYAKE LV, Palygin O, Staruschenko A
    Lysine and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Apr 22. doi: 10.1097/MNH.0000000000000994.
    PubMed     Abstract available


    March 2024
  21. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
    The TMEM16A channel as a potential therapeutic target in vascular disease.
    Curr Opin Nephrol Hypertens. 2024;33:161-169.
    PubMed     Abstract available


    January 2024
  22. DEMIRCI M, Hinton A, Kirabo A
    Dendritic cell epithelial sodium channel induced inflammation and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Jan 8. doi: 10.1097/MNH.0000000000000963.
    PubMed     Abstract available


  23. BENSON LN, Mu S
    Interferon gamma in the pathogenesis of hypertension - recent insights.
    Curr Opin Nephrol Hypertens. 2024 Jan 5. doi: 10.1097/MNH.0000000000000966.
    PubMed     Abstract available


  24. ALVAREZ-ELIAS AC, Brenner BM, Luyckx VA
    Climate change and its influence in nephron mass.
    Curr Opin Nephrol Hypertens. 2024;33:102-109.
    PubMed     Abstract available


    November 2023
  25. TANTISATTAMO E, Ferrey AJ, Reddy UG, Malik FT, et al
    A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients.
    Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000951.
    PubMed     Abstract available


  26. LUCAS B, Taal MW
    Blood pressure targets in chronic kidney disease: still no consensus.
    Curr Opin Nephrol Hypertens. 2023;32:497-501.
    PubMed     Abstract available


    September 2023
  27. CAMAFORT M, Ihm SH, Ruilope LM
    Renal denervation for the treatment of hypertension and kidney disease.
    Curr Opin Nephrol Hypertens. 2023 Sep 14. doi: 10.1097/MNH.0000000000000928.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.